Other studies have also found that TLRs/NF-κB signaling pathway and NLRP3 inflammatory body activation may lead to IL-1β–driven inflammatory response, causing hyperuricemia in kidney injury [41]. The gene discussed is NFKB1; the disease is hyperuricemia.